Low neutralisation of the omicron BA.2 sublineage in boosted individuals who had breakthrough infections.

Karaba, Andrew H; Johnston, Trevor S; Aytenfisu, Tihitina Y; Woldemeskel, Bezawit A; Garliss, Caroline C; Cox, Andrea L; Blankson, Joel N

Karaba, Andrew H; Johnston, Trevor S; Aytenfisu, Tihitina Y; Woldemeskel, Bezawit A; Garliss, Caroline C; Cox, Andrea L; Blankson, Joel N.

Karaba AH; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Johnston TS; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Aytenfisu TY; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Woldemeskel BA; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Garliss CC; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Cox AL; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Blankson JN; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. Electronic address: jblanks@jhmi.edu.

Lancet Microbe ; 3(9): e644, 2022 09.

Article in English | MEDLINE | ID: covidwho-2219210

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Topics: Vaccines / Variants Language: English Journal: Lancet Microbe Year: 2022 Document Type: Article Affiliation country: S2666-5247(22)00180-x

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google